Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Enhabit | EHAB | 17. mar 2025 | 9.01 | +5.26 |
Enhanced Short-Maturity Strgy ETF Pimco | MINT | 17. mar 2025 | 100.48 | 0.00 |
Eni ADR | E | 17. mar 2025 | 30.63 | +2.17 |
Enlight Renewable Energy | ENLT | 17. mar 2025 | 17.69 | +1.64 |
Enlightify | ENFY | 17. mar 2025 | 1.08 | -0.92 |
Enlink Midstream LLC Unit | ENLC | 17. mar 2025 | 14.12 | 0.00 |
Enliven Therapeutics | ELVN | 17. mar 2025 | 21.04 | +1.45 |
Enlivex Therapeutics | ENLV | 17. mar 2025 | 1.15 | -5.74 |
Ennis | EBF | 17. mar 2025 | 21.20 | 0.00 |
Enova International | ENVA | 17. mar 2025 | 93.17 | +0.59 |
Enovis | ENOV | 17. mar 2025 | 39.19 | +5.78 |
Enovix | ENVX | 17. mar 2025 | 8.17 | +6.80 |
Enphase Energy | ENPH | 17. mar 2025 | 63.80 | +9.75 |
Enpro | NPO | 17. mar 2025 | 178.04 | +1.35 |
Enservco | ENSV | 17. mar 2025 | 0.04 | -2.78 |
Enstar Group | ESGR | 17. mar 2025 | 332.70 | +0.23 |
Enstar Group Depository E Pref | ESGRO | 17. mar 2025 | 20.87 | +1.21 |
Enstar Pref | ESGRP | 17. mar 2025 | 21.44 | +0.37 |
Ensysce Biosciences | ENSC | 17. mar 2025 | 3.90 | +0.26 |
Entegris | ENTG | 17. mar 2025 | 100.80 | +2.47 |
Entera Bio | ENTX | 17. mar 2025 | 1.95 | +3.72 |
Entergy | ETR | 17. mar 2025 | 85.45 | +0.54 |
Entergy Texas A Pref | ETI- | 17. mar 2025 | 24.07 | 0.00 |
Entergy Utility Enterprises | EMP | 17. mar 2025 | 21.47 | +0.52 |
Entero Therapeutics | ENTO | 17. mar 2025 | 0.53 | +10.58 |
Enterprise Bancorp | EBTC | 17. mar 2025 | 39.84 | +0.78 |
Enterprise Financial Services | EFSC | 17. mar 2025 | 56.65 | +1.47 |
Enterprise Financial Services A Pref | EFSCP | 17. mar 2025 | 18.87 | +0.32 |
Enterprise Products Partners LP Unit | EPD | 17. mar 2025 | 33.92 | +0.98 |
Entrada Therapeutics | TRDA | 17. mar 2025 | 10.81 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.